Dr. Lalit Kumar Reviews

A 14-year-old street performer from Old Delhi presented with recurrent infections and was diagnosed with severe aplastic anemia; Dr. Kumar coordinated a successful haploidentical BMT using her father as donor, with post-transplant care funded through crowdfunding, leading to full hematologic recovery after 9 months.

A 68-year-old retired school principal with myelodysplastic syndrome underwent reduced-intensity conditioning BMT after Dr. Kumar discovered a rare HLA-matched unrelated donor in Germany; she experienced mild graft-versus-host disease but achieved complete remission and now volunteers counseling other elderly patients.

A 32-year-old pregnant woman at 16 weeks gestation was diagnosed with acute lymphoblastic leukemia; Dr. Kumar assembled a multidisciplinary team to administer modified chemotherapy during pregnancy followed by a postpartum cord blood transplant using her newborn's stem cells, resulting in sustained remission for both mother and child.

A 45-year-old Tibetan refugee with relapsed Hodgkin lymphoma received an allogeneic BMT after Dr. Kumar secured special humanitarian visas for the patient's siblings to travel for donor testing; the patient developed moderate chronic GVHD but returned to teaching monastic children after 18 months of targeted therapy.

An 8-year-old tribal boy from Jharkhand with beta-thalassemia major underwent a matched sibling BMT facilitated by Dr. Kumar's collaboration with a tribal healthcare initiative; the transplant was complicated by veno-occlusive disease but resolved with defibrotide, and he now attends school regularly with normal hemoglobin levels.

A 57-year-old corporate CEO with multiple myeloma received an autologous stem cell transplant combined with CAR-T therapy in a clinical trial orchestrated by Dr. Kumar; despite cytokine release syndrome requiring ICU care, he achieved minimal residual disease-negative status and returned to work within 6 months.

A 22-year-old engineering student from a remote village presented with primary myelofibrosis; Dr. Kumar performed a JAK2-targeted therapy followed by unrelated donor BMT, complicated by cytomegalovirus reactivation that was successfully managed, allowing the patient to complete his degree with academic accommodations during recovery.

A 39-year-old single mother with triple-negative breast cancer and BRCA mutation underwent high-dose chemotherapy with autologous BMT after Dr. Kumar arranged childcare support through hospital social services; she experienced prolonged neutropenia but eventually achieved pathologic complete response and started a small home business.

A 71-year-old retired army colonel with AML and cardiac comorbidities received a sequential conditioning regimen designed by Dr. Kumar to minimize cardiotoxicity; the transplant resulted in complete chimerism with no cardiac complications, and he now leads a veterans' support group for cancer survivors.

A 17-year-old with Fanconi anemia developed MDS and underwent a fludarabine-based conditioning BMT from an unrelated donor identified through international registries; Dr. Kumar managed complex drug interactions with the patient's existing androgen therapy, resulting in successful engraftment and transition to adult care.

A 50-year-old fisherman from coastal Kerala with NK/T-cell lymphoma received a BEAM conditioning regimen followed by autologous BMT; Dr. Kumar adapted the treatment schedule around monsoon fishing seasons and incorporated Ayurvedic supportive care, leading to sustained remission and return to livelihood.

A 29-year-old professional dancer with acute promyelocytic leukemia underwent ATRA-arsenic trioxide therapy followed by autologous BMT to consolidate remission; Dr. Kumar collaborated with physiotherapists to preserve joint mobility during recovery, enabling her to return to performance after 11 months.

A 63-year-old diabetic farmer with mantle cell lymphoma participated in a novel conditioning protocol combining ibrutinib with BMT; Dr. Kumar managed glycemic control throughout transplant using continuous glucose monitoring, resulting in complete metabolic response and return to agricultural work.

A 12-year-old with Wiskott-Aldrich syndrome received a cord blood transplant after Dr. Kumar facilitated import of matched units from a U.S. bank; the patient experienced immune reconstitution after 5 months and now participates in sports previously prohibited due to bleeding risk.

A 41-year-old restaurant owner with primary CNS lymphoma underwent high-dose methotrexate followed by autologous BMT with thiotepa/carmustine conditioning; Dr. Kumar coordinated neurocognitive rehabilitation that addressed chemotherapy-induced 'chemo brain,' allowing successful return to business management.